Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Mar 16, 2024; 12(8): 1530-1535
Published online Mar 16, 2024. doi: 10.12998/wjcc.v12.i8.1530
Published online Mar 16, 2024. doi: 10.12998/wjcc.v12.i8.1530
Analysis and monitoring of drug therapy in a patient with peptic ulcer complicated by infection: A case report
Yan-Ping Gou, The Second People’s Hospital of Meishan City & Renshou County People’s Hospital, Meishan 620500, Sichuan Province, China
Yue Huang, Li Chen, Yun-Hua Zheng, Quality Evaluation and Medical Record Management, The Affiliated Hospital of Southwest Jiaotong University & The Third People's Hospital of Chengdu, Chengdu 610000, Sichuan Province, China
Wei Zheng, Patriotic Health Campaign, Qionglai City Health Bureau, Chengdu 610000, Sichuan Province, China
Author contributions: Gou YP was the patient’s pharmacist; Huang Y reviewed the literature and contributed to manuscript drafting; Zheng YH, Chen L and Zheng W collected the information from the patient; Zheng YH was responsible for revision of the manuscript; Gou YP and Zheng YH reviewed and edited the paper. All authors have read and approved the final version of the manuscript.
Informed consent statement: The informed consent was obtained from the patient for the entire treatment process and publication of this paper.
Conflict-of-interest statement: The authors declare no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yun-Hua Zheng, PharmD, Assistant Lecturer, Pharmacist, Research Scientist, Senior Statistician, Quality Evaluation and Medical Record Management, The Affiliated Hospital of Southwest Jiaotong University & The Third People’s Hospital of Chengdu, No. 82 Qinglong Street, Qingyang District, Chengdu 610000, Sichuan Province, China. 13125549713@163.com
Received: December 21, 2023
Peer-review started: December 21, 2023
First decision: January 10, 2024
Revised: February 7, 2024
Accepted: February 21, 2024
Article in press: February 21, 2024
Published online: March 16, 2024
Processing time: 82 Days and 3.3 Hours
Peer-review started: December 21, 2023
First decision: January 10, 2024
Revised: February 7, 2024
Accepted: February 21, 2024
Article in press: February 21, 2024
Published online: March 16, 2024
Processing time: 82 Days and 3.3 Hours
Core Tip
Core Tip: Duodenal ulcer is a common digestive disease in clinical practice. The main treatment methods are to heal the ulcer, prevent recurrence and avoid complications. For the first time, we report a case of pharmacist in a medical institution participating in the treatment process of a patient with duodenal ulcer and pulmonary infection. It is worth noting that the drug combined with Kangfuxin Liquid had a good effect, which reminds us that individualized treatment is necessary and combination with Kangfuxin Liquid is a valuable research direction.